[EN] PHOSPHOHALOHYDRINS, METHOD FOR MAKING SAME AND USES<br/>[FR] PHOSPHOHALOHYDRINES, PROCEDE DE FABRICATION ET APPLICATIONS
申请人:INST NAT SANTE RECH MED
公开号:WO2000012516A1
公开(公告)日:2000-03-09
L'invention concerne des composés comprenant au moins un groupement phosphohalohydrine de formule (1), où X est un halogène choisi parmi I, Br, Cl, R1 est choisi parmi -CH3 et -CH2-CH3, Cat+ est un cation organique ou minéral, et n est un nombre entier compris entre 2 et 20, leurs procédés de préparation et leurs applications, notamment thérapeutiques et pour activer les lymphocytes Tη9δ2 des primates.
Phosphohalohydrins, process for the production thereof and use thereof
申请人:INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICATE
公开号:US20040087555A1
公开(公告)日:2004-05-06
The invention provides compounds comprising at least one phosphohalohydrin group of the formula:
1
where X is a halogen selected from among I, Br, Cl,
R1 is selected from among —CH
3
and —CH
2
—CH
3
,
Cat+ is an organic or inorganic cation,
and n is an integer between 2 and 20,
processes for the production thereof and uses thereof, in particular therapeutic uses and for activating primate T&ggr;9&dgr;2 lymphocytes.
Methods of Using Phosphoantigen for the Treatment of Cancer
申请人:Tiollier Jérôme
公开号:US20100029674A1
公开(公告)日:2010-02-04
The present invention relates to compositions and methods useful for treating a cancer in mammals, including humans. The methods and compositions typically comprise use of a chemotherapeutic agent and a γδ T cell activator such that the composition is effective for treating a cancer. Preferably the composition enhances the effect of the γδ T cell activator and/or prevents or delays the escape of a tumor from control chemotherapy, particularly an anti-angiogenic chemotherapeutic agent.
Phosphohalohydrins, Process For The Production Thereof And Use Thereof
申请人:Belmant Christian
公开号:US20100068179A1
公开(公告)日:2010-03-18
The invention provides compounds comprising at least one phosphohalohydrin group of the formula:
where X is a halogen selected from among I, Br, Cl,
R1 is selected from among —CH
3
and —CH
2
—CH
3
,
Cat+ is an organic or inorganic cation,
and n is an integer between 2 and 20,
processes for the production thereof and uses theroef, in particular therapeutic uses and for activating primate Tγ9δ2 lymphocytes.
The invention concerns methods for producing lymphocytic cells, as well as tools, reagents and kits useful for implementing same. More particularly, it concerns methods for preparing gamma delta T cells, adapted to industrial production of functional cells of pharmaceutical quality in large amounts. The invention also concerns methods for activating gamma delta T cells, devices adapted to said methods, as well as the resulting cell compositions and their human or animal gamma delta T cells, and can be used in pharmaceutics, therapeutics, experiments, cosmetics, industrial research among others.